CMND · Clearmind Medicine Inc.

Summary

Clearmind Medicine amended its Securities Purchase Agreement to restore $10 million in capacity for future convertible note issuances.

Key takeaways

• Subscription Amount increased by $10 million, restoring full capacity for additional convertible notes.
• Quarterly issuance cap of $2.5 million remains in place unless otherwise agreed.
• Company has no obligation to draw down any portion of the increased capacity.
• Amendment reflects continued access to financing without minimum commitment or penalty.